澳门永利娱乐场|唯一官方线上直营!

888真人赌博开户  888真人赌博开户平台  888真人赌博开户网址『官方认准』

海翔药业:2017年第一季度报告正文

时间:2018-01-12 16:12来源:网络整理 作者:采集侠 点击:
海翔药业(002099)公告正文:海翔药业:2017年第一季度报告正文

海翔药业:2017年第一季度报告正文 公告日期 2017-04-21                                                                浙江海翔药业股份有限公司 2017 年第一季度报告正文




证券代码:002099                            证券简称:海翔药业                                 公告编号:2017-022




         浙江海翔药业股份有限公司 2017 年第一季度报告正文


                                         第一节 重要提示



       公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真

实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和

连带的法律责任。

       除下列董事外,其他董事亲自出席了审议本次季报的董事会会议

     未亲自出席董事姓名       未亲自出席董事职务         未亲自出席会议原因                 被委托人姓名

朱建伟                    董事                        公出                         苏为科


       公司负责人杨思卫、主管会计工作负责人李进及会计机构负责人(会计主管

人员)朱勇声明:保证季度报告中财务报表的真实、准确、完整。


                                     第二节 公司基本情况

一、主要会计数据和财务指标

公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据
□ 是 √ 否

                                           本报告期                   上年同期            本报告期比上年同期增减

营业收入(元)                                584,239,451.12             641,700,833.98                     -8.95%

归属于上市公司股东的净利润(元)              116,313,042.33             132,935,737.97                    -12.50%

归属于上市公司股东的扣除非经常性损
                                              114,535,120.43             131,594,461.80                    -12.96%
益的净利润(元)

经营活动产生的现金流量净额(元)              116,376,241.70             173,936,219.55                    -33.09%


                                                                                                                1
                                                                       浙江海翔药业股份有限公司 2017 年第一季度报告正文


基本每股收益(元/股)                                           0.07                          0.09                        -22.22%

稀释每股收益(元/股)                                           0.07                          0.09                        -22.22%

加权平均净资产收益率                                         2.41%                        3.69%                            -1.28%

                                                                                                     本报告期末比上年度末增
                                                本报告期末                    上年度末
                                                                                                                  减

总资产(元)                                      7,232,178,678.73              6,905,599,097.34                              4.73%

归属于上市公司股东的净资产(元)                  4,895,540,888.64              4,767,696,982.49                              2.68%

非经常性损益项目和金额
√ 适用 □ 不适用
                                                                                                                         单位:元

                             项目                               年初至报告期期末金额                       说明

非流动资产处置损益(包括已计提资产减值准备的冲销部分)                           -62,622.88

计入当期损益的政府补助(与企业业务密切相关,按照国家统
                                                                               2,083,973.74
一标准定额或定量享受的政府补助除外)

除上述各项之外的其他营业外收入和支出                                             -97,076.60

减:所得税影响额                                                                146,352.36

合计                                                                           1,777,921.90                  --

对公司根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义界定的非经常性损益项目,以及把《公
开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》中列举的非经常性损益项目界定为经常性损益的项目,应
说明原因
□ 适用 √ 不适用
公司报告期不存在将根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义、列举的非经常性损益
项目界定为经常性损益的项目的情形。


二、报告期末股东总数及前十名股东持股情况表

1、普通股股东总数和表决权恢复的优先股股东数量及前 10 名股东持股情况表

                                                                                                                         单位:股

                                                                报告期末表决权恢复的优先
报告期末普通股股东总数                                 66,700                                                                     0
                                                                股股东总数(如有)

                                                 前 10 名股东持股情况

                                                                        持有有限售条件               质押或冻结情况
   股东名称            股东性质      持股比例         持股数量
                                                                          的股份数量          股份状态                 数量

浙江东港投资有
                    境内非国有法人        35.49%        576,000,000          576,000,000 质押                          365,572,000
限公司

王云富              境内自然人             7.32%        118,800,000                    0 质押                           61,800,000

杭州勤进投资有 境内非国有法人              3.94%         64,000,000           64,000,000 质押                           64,000,000


                                                                                                                                  2
                                                                 浙江海翔药业股份有限公司 2017 年第一季度报告正文


限公司

叶小青            境内自然人                1.35%       21,984,435      21,984,435 质押                      21,984,435

兴业证券-兴业
-兴业证券金麒
                  其他                      1.18%       19,094,565                 0
麟 2 号集合资产
管理计划

浙江新大集团有
                  境内非国有法人            0.89%       14,470,000                 0
限公司

全国社保基金一
                  其他                      0.80%       12,986,856                 0
一四组合

全国社保基金四
                  其他                      0.79%       12,745,878                 0
一六组合

戚跃明            境内自然人                0.75%       12,146,280                 0

中国工商银行股
份有限公司-信
诚鼎利定增灵活 其他                         0.72%       11,760,924                 0
配置混合型证券
投资基金

                                           前 10 名无限售条件股东持股情况

                                                                                                 股份种类
           股东名称                            持有无限售条件股份数量
                                                                                        股份种类            数量

王云富                                                                  118,800,000 人民币普通股            118,800,000

浙江新大集团有限公司                                                    14,470,000 人民币普通股              14,470,000

全国社保基金四一六组合                                                  12,745,878 人民币普通股              12,745,878

戚跃明                                                                  12,146,280 人民币普通股              12,146,280

俞国骅                                                                   11,085,056 人民币普通股             11,085,056

中央汇金资产管理有限责任公司                                            10,540,400 人民币普通股              10,540,400

兴业证券-兴业-兴业证券金麒麟
                                                                            8,248,262 人民币普通股            8,248,262
2 号集合资产管理计划

深圳市创新投资集团有限公司                                                  7,494,271 人民币普通股            7,494,271

中国人寿保险股份有限公司-分红
                                                                            5,499,958 人民币普通股            5,499,958
-个人分红-005L-FH002 深

陕西省国际信托股份有限公司-陕
国投永利 15 号证券投资集合资金                                              5,443,300 人民币普通股            5,443,300
信托计划

                                   1、王云富先生持有东港工贸集团 73.20%的股权,东港工贸集团持有东港投资 100.00%
上述股东关联关系或一致行动的说
                                   的股权。王云富先生直接持有上市公司 11,880 万股股份,通过东港投资间接上市公司

                                   57,600 万股股份,合计持有上市公司 69,480 万股份,为上市公司的实际控制人。2、其


                                                                                                                     3
                                                                  浙江海翔药业股份有限公司 2017 年第一季度报告正文


                                 他股东之间未知是否存在关联关系,也未知是否属于一致行动人。

公司前 10 名普通股股东、前 10 名无限售条件普通股股东在报告期内是否进行约定购回交易
□ 是 √ 否
公司前 10 名普通股股东、前 10 名无限售条件普通股股东在报告期内未进行约定购回交易。


2、公司优先股股东总数及前 10 名优先股股东持股情况表

□ 适用 √ 不适用




                                            第三节 重要事项

一、报告期主要财务数据、财务指标发生变动的情况及原因

√ 适用 □ 不适用

 资产负债项目        期末数            期初数            增减额           变动幅度                 变动原因
                                                                                        主要系本期末持有银行承兑汇票
应收票据            152,905,166.17      43,734,903.82   109,170,262.35       249.62%
                                                                                        增加所致
                                                                                        主要系收到如意实业股权转让款
其他应收款           45,347,165.10      75,453,262.98    -30,106,097.88       -39.90%
                                                                                        所致
可供出售金融资                                                                          主要系增加滨海临海资产管理有
                     21,800,000.00      11,800,000.00    10,000,000.00        84.75%
产                                                                                      限公司的股权投资所致
工程物资              3,620,493.14       7,180,992.22     -3,560,499.08       -49.58% 主要系本期工程领用所致
                                                                                        主要系本期银行承兑汇票增加所
应付票据            259,701,262.40     119,209,754.90   140,491,507.50       117.85%
                                                                                        致
预收款项             11,903,283.33       7,689,739.82      4,213,543.51       54.79% 主要系本期货款预收增加
应交税费             53,738,995.39      34,478,435.33    19,260,560.06        55.86% 主要系本期应交增值税增加所致
                                                                                        主要系本期超短期融资券计提利
应付利息              7,842,663.97       3,357,029.17      4,485,634.80      133.62%
                                                                                        息增加所致
长期借款                         -     200,000,000.00   -200,000,000.00      -100.00% 主要系本期归还贷款所致
                                                                                        主要系本期外币报表折算差异所
其他综合收益           -131,857.46         -77,529.21        -54,328.25       70.07%
                                                                                        致
利润表项目           本期数           上年同期数         增减额           变动幅度                 变动原因
                                                                                        主要系本期收款增加,坏账准备
资产减值损失         -2,157,350.64       3,400,960.28     -5,558,310.92      -163.43%
                                                                                        冲回所致
投资收益               -940,272.40        267,037.54      -1,207,309.94      -452.11% 主要系参股公司亏损所致
营业外支出             344,743.16        1,348,648.03     -1,003,904.87       -74.44% 主要系本期水利基金减少所致
现金流量表表
                    本期金额         上年同期金额        增减额           变动幅度                 变动原因
项目
经营活动产生的                                                                          主要系本期购买商品、提供劳务
                    116,376,241.70     173,936,219.55    -57,559,977.85       -33.09%
现金流量净额                                                                            支付现金同比增加所致


                                                                                                                   4
                                                                 浙江海翔药业股份有限公司 2017 年第一季度报告正文


筹资活动产生的
                     29,191,898.37   151,239,677.20     -122,047,778.83            -80.70% 主要系本期银行贷款减少所致
现金流量净额




二、重要事项进展情况及其影响和解决方案的分析说明

□ 适用 √ 不适用


三、公司实际控制人、股东、关联方、收购人以及公司等承诺相关方在报告期内超期未履行
完毕的承诺事项

□ 适用 √ 不适用
公司报告期不存在公司实际控制人、股东、关联方、收购人以及公司等承诺相关方在报告期内超期未履行完毕的承诺事项。


四、对 2017 年 1-6 月经营业绩的预计

2017 年 1-6 月预计的经营业绩情况:归属于上市公司股东的净利润为正值且不属于扭亏为盈的情形
归属于上市公司股东的净利润为正值且不属于扭亏为盈的情形

2017 年 1-6 月归属于上市公司股东的净利润变
                                                                      -21.04%         至                         -1.30%
动幅度

2017 年 1-6 月归属于上市公司股东的净利润变
                                                                          24,000      至                         30,000
动区间(万元)

2016 年 1-6 月归属于上市公司股东的净利润(万
                                                                                                              30,395.97
元)

                                               今年上半年医药、染料订单稳定,但染料产品成本略有上升,因此预计 2017
业绩变动的原因说明
                                               年 1-6 月份归属上市公司股东的净利润同比略有下降。


五、以公允价值计量的金融资产

□ 适用 √ 不适用


六、违规对外担保情况

□ 适用 √ 不适用
公司报告期无违规对外担保情况。


七、控股股东及其关联方对上市公司的非经营性占用资金情况

□ 适用 √ 不适用
公司报告期不存在控股股东及其关联方对上市公司的非经营性占用资金。




                                                                                                                        5
                                                    浙江海翔药业股份有限公司 2017 年第一季度报告正文


八、报告期内接待调研、沟通、采访等活动登记表

√ 适用 □ 不适用

         接待时间            接待方式          接待对象类型              调研的基本情况索引

                                                                 互动易平台 2017 年 2 月 9 日投资者活
2017 年 02 月 09 日   实地调研          机构
                                                                 动关系表

                                                                 互动易平台 2017 年 2 月 10 日投资者活
2017 年 02 月 10 日   实地调研          机构
                                                                 动关系表




                                                                   浙江海翔药业股份有限公司

                                                                            法定代表人:杨思卫

                                                                        二零一七年四月十九日




                                                                                                    6

(责任编辑:admin)
织梦二维码生成器
顶一下
(0)
0%
踩一下
(0)
0%
------分隔线----------------------------
发表评论
请自觉遵守互联网相关的政策法规,严禁发布色情、暴力、反动的言论。
评价:
表情:
用户名: 验证码:点击我更换图片
栏目列表
推荐内容